Midazolam Injection
Product Images NDC 0641-6059

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 0641-6059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Midazolam Injection Usp 1)

Chemical structure diagram of Midazolam hydrochloride, showing the arrangement of rings and atoms including nitrogen, chlorine, fluorine, and hydrogen within the molecule.*

FDA Label Image

Image Of Midazolam Present As An Equilibirum Mixture Of Closed-ring And Open-ring Form (Midazolam Injection Usp 2)

Chemical structure diagram showing two forms of Midazolam. The left side depicts the closed-ring form of Midazolam, while the right side shows the open-ring form. Both structures include the distinct fluorophenyl and chlorophenyl groups characteristic of Midazolam molecules.*

FDA Label Image

Image Of Chart Plotting The Percentage Of Midazolam Present As The Open-ring Form As A Function Of Ph In Aqueous Solutions (Midazolam Injection Usp 3)

A line graph titled 'pH Dependence of Open-ring Form in Water' showing the percentage of the open-ring form of Midazolam as it relates to varying pH levels. The Y-axis represents the percent open-ring form from 0 to 60%, and the X-axis represents pH values ranging from 2.5 to 5.5. The graph illustrates a sharp decrease in the percentage of the open-ring form as pH increases, leveling off near zero at higher pH values.*

FDA Label Image

462-507-05 Trimmed Thumb (Midazolam Injection Usp 4)

Midazolam injection USP 2 mg per 2 mL (1 mg/mL) vial label by Hikma Pharmaceuticals USA Inc. The label states the solution is for intramuscular or intravenous use only, includes the NDC 0641-6057-01, and displays a bar code and spaces for lot and expiration date.*

FDA Label Image

462-508-05 Thumb (Midazolam Injection Usp 5)

Midazolam Injection, USP 2 mg per 2 mL (1 mg/mL) vial label. The label indicates the product is for intramuscular or intravenous use only, contains benzyl alcohol as preservative, and provides storage instructions at 20° to 25°C (68° to 77°F). Manufactured by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. Includes lot and expiration fields as well as dosage and ingredient details in printed text.*

FDA Label Image

462-509-05 Thumb (Midazolam Injection Usp 6)

Midazolam Injection, USP 2 mg per 2 mL (1 mg/mL) vial label for intramuscular or intravenous use only. The label states it contains midazolam hydrochloride and benzyl alcohol as preservative. It includes storage instructions and manufacturing details by Hikma Pharmaceuticals USA Inc.*

FDA Label Image

462-041-05 Thumb (Midazolam Injection Usp 7)

Midazolam Injection, USP 5 mg per 5 mL (1 mg/mL) vial label by Hikma Pharmaceuticals USA Inc. This human prescription drug is for intramuscular or intravenous use only. The label includes storage instructions at 20° to 25°C (68° to 77°F) and a note to see USP Controlled Room Temperature guidelines.*

FDA Label Image

Shelfpack (Midazolam Injection Usp 8)

Midazolam Injection, USP 5 mg per 5 mL (1 mg/mL) vial label from Hikma Pharmaceuticals USA Inc. This human prescription drug label specifies use for intramuscular or intravenous injection only. The label includes active ingredient details, storage instructions, and presence of benzyl alcohol as a preservative. This package contains 10 vials of 5 mL each.*

FDA Label Image

462-043-06 Thumb (Midazolam Injection Usp 9)

Midazolam Injection, USP 10 mg per 10 mL (1 mg/mL) vial label by Hikma Pharmaceuticals USA Inc. The label states the product is for intramuscular or intravenous use only, contains benzyl alcohol, and lists midazolam hydrochloride as the active ingredient. Additional storage and handling instructions are included, along with NDC 0641-6056-01.*

FDA Label Image

Shelfpack (Midazolam Injection Usp 10)

Midazolam Injection, USP 10 mg per 10 mL (1 mg/mL) in 10 x 10 mL vials. The label indicates midazolam as the active ingredient for intramuscular or intravenous use only. It contains benzyl alcohol as a preservative. The product is manufactured by Hikma Pharmaceuticals USA Inc. in Berkeley Heights, NJ. Storage at controlled room temperature (20° to 25°C) is recommended. The label includes NDC 0641-6056-10 and notes the prescription status (Rx only).*

FDA Label Image

462-501-05 Trimmed Thumb (Midazolam Injection Usp 11)

Midazolam injection USP 5 mg/mL vial label from Hikma Pharmaceuticals USA Inc. The label specifies the drug name, strength, injection form, and administration routes as intramuscular or intravenous use only. The vial size is 1 mL, with Rx only designation and a barcode. Spaces for lot and expiration dates are provided.*

FDA Label Image

462-50205 Thumb (Midazolam Injection Usp 12)

Label for Midazolam Injection, USP 5 mg/mL by Hikma Pharmaceuticals USA Inc. It is an injectable solution for intramuscular or intravenous use only. The label notes midazolam as the active ingredient (as the hydrochloride) and includes 10 vials of 1 mL each. The label provides storage instructions, composition details, and cautions about benzyl alcohol content.*

FDA Label Image

462-503-05 Thumb (Midazolam Injection Usp 13)

Midazolam Injection, USP 5 mg/mL vial label from Hikma Pharmaceuticals USA Inc. The label indicates midazolam (as the hydrochloride), for intramuscular (IM) or intravenous (IV) use only, containing benzyl alcohol as preservative. The package contains 25 vials of 1 mL each. Storage instructions and dosage guidance are included, with details on the solution composition and pH adjustment.*

FDA Label Image

462-504-05 Trimmed Thumb (Midazolam Injection Usp 14)

Midazolam Injection, USP 10 mg per 2 mL (5 mg/mL) in a 2 mL vial, for intramuscular and intravenous use only. The label shows it contains midazolam as the hydrochloride. Manufactured by Hikma Pharmaceuticals USA Inc. The label includes the NDC number 0641-6063-01 and space for lot and expiration date.*

FDA Label Image

462-505-05 Thumb (Midazolam Injection Usp 15)

Midazolam Injection, USP 10 mg per 2 mL (5 mg/mL) vial label by Hikma Pharmaceuticals USA Inc. This prescription drug label states midazolam hydrochloride as the active ingredient, intended for intramuscular (IM) or intravenous (IV) use only. The label includes storage instructions, preservative information (benzyl alcohol), and package details for a 10-pack of 2 mL vials.*

FDA Label Image

462-506-05 Thumb (Midazolam Injection Usp 16)

Midazolam Injection, USP 10 mg per 2 mL (5 mg/mL) vial label by Hikma Pharmaceuticals USA Inc. for intramuscular or intravenous use. Contains midazolam hydrochloride with benzyl alcohol as preservative. The label includes storage instructions and NDC 0641-6063-25.*

FDA Label Image

462-049-06 Thumb (Midazolam Injection Usp 17)

Midazolam Injection, USP 5 mg/mL is a 10 mL vial labeled for intramuscular or intravenous use. The label highlights the active ingredient midazolam (as hydrochloride) with a total of 50 mg per vial. It includes a warning that the product contains benzyl alcohol. The label also displays the NDC 0641-6060-01 and the manufacturer Hikma Pharmaceuticals USA Inc.*

FDA Label Image

Shelfpack (Midazolam Injection Usp 18)

Midazolam Injection USP label, 50 mg per 10 mL (5 mg/mL) strength, for intramuscular or intravenous use only. The label indicates it contains midazolam hydrochloride with benzyl alcohol preservative. Manufactured by Hikma Pharmaceuticals USA Inc., the packaging includes storage instructions and dosage advisory.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.